CanSino Biologics Inc (CJH) — Financial Flexibility Index
CanSino Biologics Inc (CJH) has a Financial Flexibility Index of -0.07x as of June 2023. Free cash flow of €-288.61 Million (operating CF €-392.00 Million minus capex €103.39 Million) represents 0% of total liabilities (€3.93 Billion). Check CanSino Biologics Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
CanSino Biologics Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for CanSino Biologics Inc across 10 annual periods. For the full cash flow conversion analysis, see CanSino Biologics Inc (CJH) cash flow conversion.
Annual Financial Flexibility Index for CanSino Biologics Inc (2016–2025)
Year-by-year free cash flow to debt coverage for CanSino Biologics Inc. Explore cash flow to debt ratio of CanSino Biologics Inc to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.14x | €321.76 Million | €77.86 Million | €2.22 Billion | ▲ +52.7% |
| 2024 | 0.09x | €288.85 Million | €-168.79 Million | €3.05 Billion | ▲ +248.9% |
| 2023 | -0.06x | €-256.59 Million | €-916.25 Million | €4.03 Billion | ▲ +65.4% |
| 2022 | -0.18x | €-776.53 Million | €-1.85 Billion | €4.22 Billion | ▼ -118.8% |
| 2021 | 0.98x | €3.25 Billion | €2.05 Billion | €3.33 Billion | ▲ +1174.5% |
| 2020 | -0.09x | €-61.64 Million | €-349.93 Million | €677.22 Million | ▲ +23.4% |
| 2019 | -0.12x | €-37.32 Million | €-154.25 Million | €313.98 Million | ▼ -235.3% |
| 2018 | 0.09x | €25.79 Million | €-123.64 Million | €293.56 Million | ▼ -79.0% |
| 2017 | 0.42x | €108.17 Million | €-56.30 Million | €259.03 Million | ▼ -49.1% |
| 2016 | 0.82x | €91.70 Million | €-34.38 Million | €111.70 Million | — |